Chimerix Liabilities And Stockholders Equity from 2010 to 2024

CMRX Stock  USD 0.90  0.01  1.12%   
Chimerix Liabilities And Stockholders Equity yearly trend continues to be fairly stable with very little volatility. Liabilities And Stockholders Equity will likely drop to about 197 M in 2024. Liabilities And Stockholders Equity is the total of all liabilities and equity in the company, which should equal Chimerix's total assets according to the accounting equation. View All Fundamentals
 
Liabilities And Stockholders Equity  
First Reported
2012-12-31
Previous Quarter
178.5 M
Current Value
158.7 M
Quarterly Volatility
92.8 M
 
Yuan Drop
 
Covid
Check Chimerix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Chimerix's main balance sheet or income statement drivers, such as Depreciation And Amortization of 86.5 K, Interest Expense of 3.2 M or Selling General Administrative of 20.2 M, as well as many indicators such as Price To Sales Ratio of 276, Dividend Yield of 0.0 or PTB Ratio of 0.42. Chimerix financial statements analysis is a perfect complement when working with Chimerix Valuation or Volatility modules.
  
Check out the analysis of Chimerix Correlation against competitors.
For more information on how to buy Chimerix Stock please use our How to Invest in Chimerix guide.

Latest Chimerix's Liabilities And Stockholders Equity Growth Pattern

Below is the plot of the Liabilities And Stockholders Equity of Chimerix over the last few years. It is the total of all liabilities and equity in the company, which should equal the company's total assets according to the accounting equation. Chimerix's Liabilities And Stockholders Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Chimerix's overall financial position and show how it may be relating to other accounts over time.
Liabilities And Stockholders Equity10 Years Trend
Slightly volatile
   Liabilities And Stockholders Equity   
       Timeline  

Chimerix Liabilities And Stockholders Equity Regression Statistics

Arithmetic Mean170,041,368
Geometric Mean127,305,808
Coefficient Of Variation63.06
Mean Deviation91,915,810
Median190,714,000
Standard Deviation107,231,571
Sample Variance11498.6T
Range330.6M
R-Value0.35
Mean Square Error10905.1T
R-Squared0.12
Significance0.21
Slope8,283,717
Total Sum of Squares160980.5T

Chimerix Liabilities And Stockholders Equity History

2024197 M
2023212.8 M
2022279.3 M
2021100.5 M
202084.7 M
2019119.4 M
2018190.7 M

About Chimerix Financial Statements

Chimerix investors use historical fundamental indicators, such as Chimerix's Liabilities And Stockholders Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Chimerix. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Liabilities And Stockholders Equity212.8 M197 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Chimerix Stock Analysis

When running Chimerix's price analysis, check to measure Chimerix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chimerix is operating at the current time. Most of Chimerix's value examination focuses on studying past and present price action to predict the probability of Chimerix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chimerix's price. Additionally, you may evaluate how the addition of Chimerix to your portfolios can decrease your overall portfolio volatility.